Vaccination with MenACWY and MenB is recommended for adolescents and which other group?

• A. Adolescents and certain high-risk adults.
• B. Healthy adults under 30 only.
• C. Infants under 12 months.
• D. No additional groups beyond adolescents.

Answer: (A)

Vaccination against meningococcal disease is routine for adolescents, but there are additional recommendations for people who are at higher risk as adults. Certain high‑risk adults—such as those with functional or anatomic asplenia, persistent complement deficiencies, immune system problems, or those exposed in outbreak situations or with specific occupational risks—should also receive MenACWY and MenB vaccines. This is why the best answer is that adolescents are vaccinated along with these higher‑risk adults. The other options don’t fit because healthy adults under 30 without risk factors aren’t routinely targeted, infants under 12 months aren’t the group in question, and saying no additional groups are needed contradicts the high‑risk adult recommendation.